Literature DB >> 15919755

Overexpression of twisted gastrulation inhibits bone morphogenetic protein action and prevents osteoblast cell differentiation in vitro.

Elisabetta Gazzerro1, Valerie Deregowski, Sergio Vaira, Ernesto Canalis.   

Abstract

Twisted gastrulation (Tsg) is a secreted glycoprotein that binds bone morphogenetic protein-2 (BMP-2) and BMP-4 and can display both BMP agonist and antagonist functions. Tsg acts as a BMP agonist in chondrocytes, but its expression and actions on the differentiation of cells of the osteoblastic lineage are not known. We investigated the effects of Tsg overexpression by transducing murine ST-2 stromal and MC3T3 cells with a retroviral vector where Tsg is under control of the cytomegalovirus promoter and compared them to cells transduced with the parental vector alone. ST-2 cells were cultured in osteoblastic differentiating conditions in the presence or absence of BMP-2. Tsg overexpression precluded the appearance of mineralized nodules induced by BMP-2, led to a delay in the expression of osteoblastic gene markers, and decreased the responsiveness of ST-2 differentiating cells to PTH. BMP-2 induced the phosphorylation of signaling mothers against decapentaplegic-1/5/8, but not ERK, c-Jun N-terminal kinase, and p38. ST-2 cells overexpressing Tsg displayed an inhibition of BMP/signaling mother against decapentaplegic signaling. Tsg action was specific to BMP, because Tsg overexpression did not affect TGF-beta or Wnt/beta-catenin signaling pathways. Tsg also opposed MC3T3 cell differentiation and the expression of a mature osteoblast phenotype. In conclusion, Tsg overexpression inhibits BMP action in stromal and preosteoblastic cells and, accordingly, arrests their differentiation toward the osteoblastic pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15919755     DOI: 10.1210/en.2005-0053

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Regulation of osteogenic differentiation of rat bone marrow stromal cells on 2D nanorod substrates.

Authors:  Gagandeep Kaur; Mani T Valarmathi; Jay D Potts; Esmaiel Jabbari; Tara Sabo-Attwood; Qian Wang
Journal:  Biomaterials       Date:  2009-12-22       Impact factor: 12.479

Review 2.  Agonists and Antagonists of TGF-β Family Ligands.

Authors:  Chenbei Chang
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-08-01       Impact factor: 10.005

3.  CCAAT/Enhancer-binding protein homologous protein (CHOP) decreases bone formation and causes osteopenia.

Authors:  Renata C Pereira; Lisa E Stadmeyer; Deanna L Smith; Sheila Rydziel; Ernesto Canalis
Journal:  Bone       Date:  2006-11-07       Impact factor: 4.398

4.  Connective tissue growth factor enhances osteoblastogenesis in vitro.

Authors:  Anna Smerdel-Ramoya; Stefano Zanotti; Valerie Deregowski; Ernesto Canalis
Journal:  J Biol Chem       Date:  2008-06-25       Impact factor: 5.157

5.  Skeletal overexpression of connective tissue growth factor impairs bone formation and causes osteopenia.

Authors:  Anna Smerdel-Ramoya; Stefano Zanotti; Lisa Stadmeyer; Deena Durant; Ernesto Canalis
Journal:  Endocrinology       Date:  2008-06-05       Impact factor: 4.736

6.  Fibulin-1 is required for bone formation and Bmp-2-mediated induction of Osterix.

Authors:  Marion A Cooley; Keerthi Harikrishnan; James A Oppel; Sloan F Miler; Jeremy L Barth; Courtney J Haycraft; Sakamuri V Reddy; W Scott Argraves
Journal:  Bone       Date:  2014-09-06       Impact factor: 4.398

7.  Enhanced osteoclastogenesis causes osteopenia in twisted gastrulation-deficient mice through increased BMP signaling.

Authors:  Julio E Sotillo Rodriguez; Kim C Mansky; Eric D Jensen; Ann E Carlson; Toni Schwarz; Lan Pham; BreAnne MacKenzie; Hari Prasad; Michael D Rohrer; Anna Petryk; Rajaram Gopalakrishnan
Journal:  J Bone Miner Res       Date:  2009-11       Impact factor: 6.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.